276 related articles for article (PubMed ID: 25238203)
1. miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1.
Colamaio M; Puca F; Ragozzino E; Gemei M; Decaussin-Petrucci M; Aiello C; Bastos AU; Federico A; Chiappetta G; Del Vecchio L; Torregrossa L; Battista S; Fusco A
J Clin Endocrinol Metab; 2015 Jan; 100(1):E59-69. PubMed ID: 25238203
[TBL] [Abstract][Full Text] [Related]
2. miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting.
Colamaio M; Borbone E; Russo L; Bianco M; Federico A; Califano D; Chiappetta G; Pallante P; Troncone G; Battista S; Fusco A
J Clin Endocrinol Metab; 2011 Dec; 96(12):E1915-24. PubMed ID: 21956418
[TBL] [Abstract][Full Text] [Related]
3. miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas.
Borrelli N; Denaro M; Ugolini C; Poma AM; Miccoli M; Vitti P; Miccoli P; Basolo F
Mod Pathol; 2017 Jan; 30(1):39-51. PubMed ID: 27586203
[TBL] [Abstract][Full Text] [Related]
4. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
[TBL] [Abstract][Full Text] [Related]
5. Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene.
Colamaio M; Calì G; Sarnataro D; Borbone E; Pallante P; Decaussin-Petrucci M; Nitsch L; Croce CM; Battista S; Fusco A
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2168-78. PubMed ID: 22965940
[TBL] [Abstract][Full Text] [Related]
6. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2.
Esposito F; Tornincasa M; Pallante P; Federico A; Borbone E; Pierantoni GM; Fusco A
J Clin Endocrinol Metab; 2012 May; 97(5):E710-8. PubMed ID: 22399519
[TBL] [Abstract][Full Text] [Related]
8. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA GAS5 Targeting miR-221-3p/Cyclin-Dependent Kinase Inhibitor 2B Axis Regulates Follicular Thyroid Carcinoma Cell Cycle and Proliferation.
Liu Y; Li YF; Liu J; Deng ZG; Zeng L; Zhou WB
Pathobiology; 2021; 88(4):289-300. PubMed ID: 34130294
[TBL] [Abstract][Full Text] [Related]
10. Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
Wojtas B; Ferraz C; Stokowy T; Hauptmann S; Lange D; Dralle H; Musholt T; Jarzab B; Paschke R; Eszlinger M
Mol Cell Endocrinol; 2014 May; 388(1-2):1-9. PubMed ID: 24631480
[TBL] [Abstract][Full Text] [Related]
11. miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
Xiong Y; Kotian S; Zeiger MA; Zhang L; Kebebew E
PLoS One; 2015; 10(8):e0130496. PubMed ID: 26244545
[TBL] [Abstract][Full Text] [Related]
12. Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma.
Xu B; Qin T; Yu J; Giordano TJ; Sartor MA; Koenig RJ
J Biol Chem; 2020 Jun; 295(26):8834-8845. PubMed ID: 32398261
[TBL] [Abstract][Full Text] [Related]
13. Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular Thyroid Carcinoma.
Sun D; Han S; Liu C; Zhou R; Sun W; Zhang Z; Qu J
Med Sci Monit; 2016 Apr; 22():1210-7. PubMed ID: 27062921
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
[TBL] [Abstract][Full Text] [Related]
15. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
Weber F; Teresi RE; Broelsch CE; Frilling A; Eng C
J Clin Endocrinol Metab; 2006 Sep; 91(9):3584-91. PubMed ID: 16822819
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
Dettmer M; Vogetseder A; Durso MB; Moch H; Komminoth P; Perren A; Nikiforov YE; Nikiforova MN
J Clin Endocrinol Metab; 2013 Jan; 98(1):E1-7. PubMed ID: 23150679
[TBL] [Abstract][Full Text] [Related]
17. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
[TBL] [Abstract][Full Text] [Related]
18. MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha.
Leone V; D'Angelo D; Rubio I; de Freitas PM; Federico A; Colamaio M; Pallante P; Medeiros-Neto G; Fusco A
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1388-98. PubMed ID: 21752897
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment.
Camacho CP; Latini FR; Oler G; Hojaij FC; Maciel RM; Riggins GJ; Cerutti JM
Clin Endocrinol (Oxf); 2009 Mar; 70(3):475-83. PubMed ID: 18727708
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
